Whole-Body Wellness Through Medical Weight Loss

---

Semaglutide is a medication classified as a GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist). It has been used in the management of type 2 diabetes and is FDA-approved for chronic weight management in individuals who meet specific clinical criteria.

Under the brand name Wegovy, semaglutide is approved for adults with:

• A body mass index (BMI) of 30 or greater, or
   
• A BMI of 27 or greater with at least one weight-related health condition, such as hypertension or dyslipidemia
   

Semaglutide works by influencing appetite regulation and metabolic signaling, which may help support sustainable weight management when combined with medical supervision and lifestyle guidance.

Potential benefits may include:

• Support for improved blood sugar regulation
   
• Assistance with appetite control and portion awareness
   
• Support for gradual, clinically guided weight loss
   
• Potential cardiovascular benefits in appropriate populations
   

Clinical studies have shown meaningful weight reduction in some individuals; however, results vary and depend on individual health factors, adherence, and ongoing medical oversight.

Semaglutide is generally well tolerated, though side effects can occur. These may include:

• Gastrointestinal symptoms such as nausea, vomiting, diarrhea, or constipation (most common during dose adjustment)
   
• Low blood sugar when used alongside certain diabetes medications
   
• Gallbladder-related concerns in some individuals
   
• Rare but serious risks, including pancreatitis or kidney-related issues
   

Because of these considerations, semaglutide is prescribed only after clinical evaluation and is monitored throughout treatment.

At Restore Medical, semaglutide is offered as part of a comprehensive, clinician-guided medical weight management program. Care begins with laboratory testing and a medical review to ensure therapy is appropriate, followed by individualized planning and ongoing monitoring.

Our focus is not rapid weight loss, but safe, sustainable progress supported by medical oversight.

Tirzepatide is a prescription medication approved for the treatment of type 2 diabetes and is currently being studied for its potential role in medical weight management. It is a dual-action medication that targets two hormone pathways involved in blood sugar regulation and appetite signaling.

Tirzepatide works by mimicking the activity of:

• GLP-1 (glucagon-like peptide-1)
   
• GIP (glucose-dependent insulinotropic polypeptide)
   

Together, these pathways play a role in metabolic regulation and satiety.

In clinical studies, tirzepatide has been shown to support meaningful weight reduction in some individuals, particularly those with type 2 diabetes or obesity. Ongoing research continues to evaluate its role in chronic weight management.

Weight-related outcomes vary and depend on individual health factors, medical history, and adherence to a provider-guided treatment plan.

When prescribed and monitored appropriately, tirzepatide may support:

• Improved blood sugar control
   
• Appetite regulation and reduced caloric intake
   
• Gradual, clinically supervised weight reduction
   
• Metabolic and cardiovascular risk management in appropriate populations
   

Tirzepatide is generally well tolerated, though side effects may occur, particularly during early dose adjustment. These may include:

• Gastrointestinal symptoms such as nausea, vomiting, diarrhea, or constipation
   
• Low blood sugar when combined with certain diabetes medications
   
• Mild injection-site reactions
   

Because of these considerations, tirzepatide is prescribed only after medical evaluation and requires ongoing monitoring.

At Restore Medical, tirzepatide is considered as part of a comprehensive, clinician-guided metabolic and weight management program. Care begins with laboratory testing and a detailed medical review to determine whether therapy is appropriate.

Treatment plans are individualized, monitored over time, and adjusted based on safety, response, and long-term health goals.

Phentermine is a prescription medication used as a short-term adjunct in medical weight management for individuals who meet specific clinical criteria. It is classified as a sympathomimetic amine and works by affecting appetite regulation through the central nervous system.

Phentermine is prescribed only as part of a comprehensive, clinician-guided weight management plan that includes nutritional guidance, lifestyle modification, and medical oversight.

Phentermine may be considered for short-term use in adults with:

• A BMI of 30 or greater, or
   
• A BMI of 27 or greater with weight-related health conditions such as hypertension, diabetes, or dyslipidemia
   

The duration of therapy is limited and determined by provider evaluation, patient response, and safety considerations.

When used appropriately and under medical supervision, phentermine may help support:

• Appetite regulation during early stages of weight loss
   
• Initial adherence to dietary and behavioral changes
   
• Short-term weight reduction as part of a broader plan
   

It is not intended for long-term or standalone use.

Phentermine may cause side effects, particularly due to its stimulant properties. These may include:

• Insomnia, restlessness, dizziness, or headaches
   
• Increased heart rate or blood pressure
   
• Dry mouth, constipation, or gastrointestinal discomfort
   
• Mood changes such as anxiety or irritability
   

Because phentermine is a controlled substance, careful screening, monitoring, and follow-up are required. It is not appropriate for all individuals.

At Restore Medical, phentermine is prescribed selectively and only after a comprehensive medical evaluation. Ongoing monitoring helps ensure therapy remains appropriate, safe, and aligned with long-term health goals.

Our focus is on sustainable weight management, not rapid or stimulant-dependent weight loss.